0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Viewpoint |  FREE ONLINE FIRST
Angela K. Green, MD, MSc; William A. Wood, MD, MPH; Ethan M. Basch, MD, MSc
JAMA. Published online August 25, 2016. doi:10.1001/jama.2016.12770
Includes: Supplemental Content

Special Communication |  FREE
Aaron S. Kesselheim, MD, JD, MPH; Jerry Avorn, MD; Ameet Sarpatwari, JD, PhD
JAMA. 2016;316(8):858-871. doi:10.1001/jama.2016.11237.
Includes: CME

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;316(7):703. doi:10.1001/jama.2016.10684.

Original Investigation | 
Dhruv S. Kazi, MD, MSc, MS; Andrew E. Moran, MD, MPH; Pamela G. Coxson, PhD; et al.
JAMA. 2016;316(7):743-753. doi:10.1001/jama.2016.11004.
Includes: CME, Supplemental Content

Capitol Health Call | 
Rita Rubin, MA
JAMA. 2016;316(6):575. doi:10.1001/jama.2016.10615.

Viewpoint | 
Humayun J. Chaudhry, DO, MS; Arthur S. Hengerer, MD; Gregory B. Snyder, MD
JAMA. 2016;316(6):577-578. doi:10.1001/jama.2016.7741.

Original Investigation | 
Suetonia C. Palmer, PhD; Dimitris Mavridis, PhD; Antonio Nicolucci, MD; et al.
JAMA. 2016;316(3):313-324. doi:10.1001/jama.2016.9400.
Includes: Supplemental Content

From the JAMA Network | 
Ameet Sarpatwari, JD, PhD; Aaron S. Kesselheim, MD, JD, MPH
JAMA. 2016;315(24):2724-2725. doi:10.1001/jama.2016.3851.
Includes: Supplemental Content

JAMA Patient Page |  FREE
Aria A. Razmaria, MD, MSc
JAMA. 2016;315(24):2746. doi:10.1001/jama.2016.3990.
Includes: Supplemental Content

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;315(23):2514. doi:10.1001/jama.2016.7290.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Research Letter  | 
Capecitabine and the Risk of Fingerprint Loss
Leni van Doorn, MSc; Sebastiaan Veelenturf, MSc; Lisette Binkhorst, PharmD, PhD; et al.
JAMA Oncology
Review  | 
The Role of Genetic Testing in the Selection of Therapy for Breast Cancer A Review
Polly Niravath, MD; Burcu Cakar, MD; Matthew Ellis, MB, BChir, PhD, FRCP
JAMA Cardiology
JAMA Cardiology Clinical Evidence Synopsis  | 
Nurse-Led Titration of Angiotensin-Converting Enzyme Inhibitors, β-Adrenergic Blocking Agents, and Angiotensin Receptor Blockers in Patients With Heart Failure With Reduced Ejection Fraction
Andrea Driscoll, NP, PhD; Judy Currey, PhD; Andrew Maxwell Tonkin, MD
JAMA Internal Medicine
Invited Commentary  | 
Medication Review After a Fracture—Absolutely Essential
Sarah D. Berry, MD, MPH; Douglas P. Kiel, MD, MPH